# GRIN2A

## Overview
The GRIN2A gene encodes the GluN2A subunit of the N-methyl-D-aspartate (NMDA) receptor, a pivotal component of excitatory neurotransmission in the central nervous system. The NMDA receptor is a ligand-gated ion channel that plays a crucial role in synaptic plasticity, learning, and memory. The GluN2A subunit, specifically, is integral to the receptor's function, influencing synaptic delivery, localization, and the kinetics of excitatory postsynaptic currents. Structurally, the GluN2A protein comprises several domains, including an extracellular amino-terminal domain, an agonist binding domain, a transmembrane domain, and an intracellular carboxyl-terminal domain, which collectively contribute to its physiological roles and regulation (Hansen2021Structure; Xu2024De). Mutations in GRIN2A are associated with various neurological and psychiatric disorders, highlighting its significance in normal brain function and development (Benke2021Clinical; Harrison2023GRIN2A).

## Structure
The GRIN2A gene encodes the GluN2A subunit of the NMDA receptor, which is a ligand-gated ion channel crucial for excitatory neurotransmission in the brain. The protein structure includes several key domains: an extracellular amino-terminal domain (NTD), an agonist binding domain (ABD), a transmembrane domain (TMD) with three transmembrane helices (M1, M3, M4) and a re-entrant loop (M2), and an intracellular carboxyl-terminal domain (CTD) (Hansen2021Structure; Xu2024De).

The M3 helix, containing the conserved SYTANLAAF motif, is critical for channel gating and is intolerant to variation, with mutations in this region potentially leading to neurological disorders (Xu2024De). The TMD forms the pore of the receptor, with the M2 loop controlling ion selectivity and the M3 helices acting as an activation gate (Hansen2021Structure).

Post-translational modifications such as phosphorylation and glycosylation are common, affecting receptor trafficking, localization, and degradation (Hansen2021Structure). Alternative splicing results in different isoforms of GluN2A, including a primate-specific short form of the CTD (Hansen2021Structure). These structural features are essential for the receptor's physiological roles and regulation in the central nervous system.

## Function
The GRIN2A gene encodes the GluN2A subunit of the N-methyl-D-aspartate receptor (NMDAR), a critical component of excitatory synaptic transmission in the central nervous system. NMDARs are tetrameric assemblies typically composed of two GluN1 and two GluN2 subunits, with GluN2A binding L-glutamate, essential for receptor activation (Myers2019Distinct). The GluN2A subunit is involved in synaptic delivery and localization, even in the absence of PDZ binding, and is associated with postsynaptic density 95 (PSD95) (Paoletti2013NMDA).

GluN2A-containing NMDARs have a higher open probability and faster deactivation time course compared to GluN2B-containing NMDARs, resulting in faster synaptic currents (Myers2019Distinct). This subunit is crucial for synaptic plasticity, affecting the decay kinetics of NMDA-mediated excitatory postsynaptic currents (EPSCs) and is involved in activity-dependent synaptic changes (Paoletti2013NMDA). The expression of GluN2A is low prenatally but increases significantly after birth, indicating its importance in postnatal brain development (Strehlow2018GRIN2Arelated).

GluN2A signaling is associated with dendrite refinement and stability in glutamatergic neurons, promoting synapse maturation and stabilization (Hansen2021Structure). The subunit's role in synaptic plasticity and cognitive functions is essential for normal neuronal function and signaling in healthy human cells (Traynelis2010Glutamate).

## Clinical Significance
Mutations in the GRIN2A gene, which encodes the GluN2A subunit of the NMDA receptor, are associated with a range of neurological and psychiatric disorders. These include epilepsy-aphasia spectrum disorders such as Landau-Kleffner syndrome, continuous spike-and-wave during slow-wave sleep syndrome, and benign epilepsy with centrotemporal spikes (Li2020Clinical; von2017Epilepsy). GRIN2A mutations can lead to both gain-of-function and loss-of-function effects, impacting receptor function and contributing to conditions like early-onset epileptic encephalopathy, characterized by intractable seizures and cognitive impairment (Myers2019Distinct; Yuan2014Functional).

In addition to epilepsy, GRIN2A mutations are linked to intellectual disabilities and speech disorders, with a significant proportion of affected individuals experiencing varying degrees of intellectual disability and speech impairments (Amador2020Modelling; Benke2021Clinical). The gene is also implicated in schizophrenia, with both rare and common variants contributing to genetic risk. These mutations are associated with cognitive deficits and neuropsychiatric comorbidities, likely due to haploinsufficiency and loss of function (Harrison2023GRIN2A). The phenotypic consequences of GRIN2A mutations underscore the gene's critical role in neurodevelopmental and psychiatric disorders.

## Interactions
GRIN2A, a subunit of the NMDA receptor, is involved in several critical protein interactions that influence synaptic plasticity and neuronal communication. It interacts with the p140Cap protein, which serves as a hub for proteins implicated in psychiatric and neurological disorders. This interaction was validated through immunoprecipitation techniques, confirming that GRIN2A is part of a macromolecular complex involving p140Cap at synapses (Alfieri2017Synaptic). GRIN2A is also associated with other NMDA receptor subunits, such as Grin2b and Grin1, which are crucial for synaptic plasticity, learning, and memory (Alfieri2017Synaptic).

The protein is linked to a network of interactions involving postsynaptic density proteins like Dlg4/PSD95, Shank2, Shank3, Homer1, and Camk2a, which are known to affect long-term potentiation (LTP) and long-term depression (LTD) (Alfieri2017Synaptic). These interactions are significant in the context of synaptic signaling and receptor localization, impacting neuronal communication and plasticity. GRIN2A's involvement in these networks highlights its role in the pathophysiology of disorders such as schizophrenia, intellectual disability, epilepsy, and autism spectrum disorder (Alfieri2017Synaptic).


## References


[1. (Amador2020Modelling) Ariadna Amador, Christopher D Bostick, Heather Olson, Jurrian Peters, Chad R Camp, Daniel Krizay, Wenjuan Chen, Wei Han, Weiting Tang, Ayla Kanber, Sukhan Kim, JiaJie Teoh, Megha Sah, Sabrina Petri, Hunki Paek, Ana Kim, Cathleen M Lutz, Mu Yang, Scott J Myers, Subhrajit Bhattacharya, Hongjie Yuan, David B Goldstein, Annapurna Poduri, Michael J Boland, Stephen F Traynelis, and Wayne N Frankel. Modelling and treating grin2a developmental and epileptic encephalopathy in mice. Brain, 143(7):2039–2057, June 2020. URL: http://dx.doi.org/10.1093/brain/awaa147, doi:10.1093/brain/awaa147. This article has 66 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awaa147)

[2. (von2017Epilepsy) C. von Stülpnagel, M. Ensslen, R.S. Møller, D.K. Pal, S. Masnada, P. Veggiotti, E. Piazza, M. Dreesmann, T. Hartlieb, T. Herberhold, E. Hughes, M. Koch, C. Kutzer, K. Hoertnagel, J. Nitanda, M. Pohl, K. Rostásy, T.B. Haack, K. Stöhr, G. Kluger, and I. Borggraefe. Epilepsy in patients with grin2a alterations: genetics, neurodevelopment, epileptic phenotype and response to anticonvulsive drugs. European Journal of Paediatric Neurology, 21(3):530–541, May 2017. URL: http://dx.doi.org/10.1016/j.ejpn.2017.01.001, doi:10.1016/j.ejpn.2017.01.001. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejpn.2017.01.001)

[3. (Traynelis2010Glutamate) Stephen F. Traynelis, Lonnie P. Wollmuth, Chris J. McBain, Frank S. Menniti, Katie M. Vance, Kevin K. Ogden, Kasper B. Hansen, Hongjie Yuan, Scott J. Myers, and Ray Dingledine. Glutamate receptor ion channels: structure, regulation, and function. Pharmacological Reviews, 62(3):405–496, August 2010. URL: http://dx.doi.org/10.1124/pr.109.002451, doi:10.1124/pr.109.002451. This article has 2813 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pr.109.002451)

[4. (Alfieri2017Synaptic) Annalisa Alfieri, Oksana Sorokina, Annie Adrait, Costanza Angelini, Isabella Russo, Alessandro Morellato, Michela Matteoli, Elisabetta Menna, Elisabetta Boeri Erba, Colin McLean, J. Douglas Armstrong, Ugo Ala, Joseph D. Buxbaum, Alfredo Brusco, Yohann Couté, Silvia De Rubeis, Emilia Turco, and Paola Defilippi. Synaptic interactome mining reveals p140cap as a new hub for psd proteins involved in psychiatric and neurological disorders. Frontiers in Molecular Neuroscience, June 2017. URL: http://dx.doi.org/10.3389/fnmol.2017.00212, doi:10.3389/fnmol.2017.00212. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2017.00212)

[5. (Benke2021Clinical) Tim A. Benke, Kristen Park, Ilona Krey, Chad R. Camp, Rui Song, Amy J. Ramsey, Hongjie Yuan, Stephen F. Traynelis, and Johannes Lemke. Clinical and therapeutic significance of genetic variation in the grin gene family encoding nmdars. Neuropharmacology, 199:108805, November 2021. URL: http://dx.doi.org/10.1016/j.neuropharm.2021.108805, doi:10.1016/j.neuropharm.2021.108805. This article has 39 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuropharm.2021.108805)

[6. (Strehlow2018GRIN2Arelated) Vincent Strehlow, Henrike O Heyne, Danique R M Vlaskamp, Katie F M Marwick, Gabrielle Rudolf, Julitta de Bellescize, Saskia Biskup, Eva H Brilstra, Oebele F Brouwer, Petra M C Callenbach, Julia Hentschel, Edouard Hirsch, Peter C Kind, Cyril Mignot, Konrad Platzer, Patrick Rump, Paul A Skehel, David J A Wyllie, Giles E Hardingham, Conny M A van Ravenswaaij-Arts, Gaetan Lesca, Johannes R Lemke, Alexis Arzimanoglou, Paul B Augustijn, Patrick Van Bogaert, Helene Bourry, Peter Burfeind, Yoyo Chu, Brian Chung, Diane Doummar, Patrick Edery, Aviva Fattal-Valevski, Mélanie Fradin, Marion Gerard, Christa de Geus, Boudewijn Gunning, Danielle Hasaerts, Ingo Helbig, Katherine L Helbig, Rami Jamra, Mélanie Jennesson Lyver, Jolien S Klein Wassink-Ruiter, David A Koolen, Damien Lederer, Roelineke J Lunsing, Mikaël Mathot, Hélène Maurey, Shay Menascu, Anne Michel, Ghayda Mirzaa, Diana Mitter, Hiltrud Muhle, Rikke S Møller, Caroline Nava, Margaret O’Brien, Evelyn van Pinxteren-Nagler, Anne van Riesen, Christelle Rougeot, Damien Sanlaville, Jolanda H Schieving, Steffen Syrbe, Hermine E Veenstra-Knol, Nienke Verbeek, Dorothée Ville, Yvonne J Vos, Pascal Vrielynck, Sabrina Wagner, Sarah Weckhuysen, and Marjolein H Willemsen. Grin2a-related disorders: genotype and functional consequence predict phenotype. Brain, 142(1):80–92, December 2018. URL: http://dx.doi.org/10.1093/brain/awy304, doi:10.1093/brain/awy304. This article has 153 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awy304)

[7. (Li2020Clinical) Xiao Li, Ling-Ling Xie, Wei Han, Si-Qi Hong, Jian-Nan Ma, Juan Wang, and Li Jiang. Clinical forms and grin2a genotype of severe end of epileptic-aphasia spectrum disorder. Frontiers in Pediatrics, November 2020. URL: http://dx.doi.org/10.3389/fped.2020.574803, doi:10.3389/fped.2020.574803. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2020.574803)

[8. (Paoletti2013NMDA) Pierre Paoletti, Camilla Bellone, and Qiang Zhou. Nmda receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nature Reviews Neuroscience, 14(6):383–400, May 2013. URL: http://dx.doi.org/10.1038/nrn3504, doi:10.1038/nrn3504. This article has 1911 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nrn3504)

[9. (Hansen2021Structure) Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, Hiro Furukawa, Frank S. Menniti, Alexander I. Sobolevsky, Geoffrey T. Swanson, Sharon A. Swanger, Ingo H. Greger, Terunaga Nakagawa, Chris J. McBain, Vasanthi Jayaraman, Chian-Ming Low, Mark L. Dell’Acqua, Jeffrey S. Diamond, Chad R. Camp, Riley E. Perszyk, Hongjie Yuan, and Stephen F. Traynelis. Structure, function, and pharmacology of glutamate receptor ion channels. Pharmacological Reviews, 73(4):1469–1658, October 2021. URL: http://dx.doi.org/10.1124/pharmrev.120.000131, doi:10.1124/pharmrev.120.000131. This article has 274 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pharmrev.120.000131)

[10. (Harrison2023GRIN2A) Paul J. Harrison and David M. Bannerman. Grin2a (nr2a): a gene contributing to glutamatergic involvement in schizophrenia. Molecular Psychiatry, 28(9):3568–3572, September 2023. URL: http://dx.doi.org/10.1038/s41380-023-02265-y, doi:10.1038/s41380-023-02265-y. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41380-023-02265-y)

[11. (Xu2024De) Yuchen Xu, Rui Song, Riley E. Perszyk, Wenjuan Chen, Sukhan Kim, Kristen L. Park, James P. Allen, Kelsey A. Nocilla, Jing Zhang, Wenshu XiangWei, Anel Tankovic, Ellington D. McDaniels, Rehan Sheikh, Ruth K. Mizu, Manish M. Karamchandani, Chun Hu, Hirofumi Kusumoto, Joseph Pecha, Gerarda Cappuccio, John Gaitanis, Jennifer Sullivan, Vandana Shashi, Slave Petrovski, Robin-Tobias Jauss, Hyun Kyung Lee, Xiuhua Bozarth, David R. Lynch, Ingo Helbig, Tyler Mark Pierson, Cornelius F. Boerkoel, Scott J. Myers, Johannes R. Lemke, Timothy A. Benke, Hongjie Yuan, and Stephen F. Traynelis. De novo grin variants in m3 helix associated with neurological disorders control channel gating of nmda receptor. Cellular and Molecular Life Sciences, March 2024. URL: http://dx.doi.org/10.1007/s00018-023-05069-z, doi:10.1007/s00018-023-05069-z. This article has 3 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-023-05069-z)

[12. (Myers2019Distinct) Scott J Myers, Hongjie Yuan, Jing-Qiong Kang, Francis Chee Kuan Tan, Stephen F Traynelis, and Chian-Ming Low. Distinct roles of grin2a and grin2b variants in neurological conditions. F1000Research, 8:1940, November 2019. URL: http://dx.doi.org/10.12688/f1000research.18949.1, doi:10.12688/f1000research.18949.1. This article has 104 citations and is from a peer-reviewed journal.](https://doi.org/10.12688/f1000research.18949.1)

[13. (Yuan2014Functional) Hongjie Yuan, Kasper B. Hansen, Jing Zhang, Tyler Mark Pierson, Thomas C. Markello, Karin V. Fuentes Fajardo, Conisha M. Holloman, Gretchen Golas, David R. Adams, Cornelius F. Boerkoel, William A. Gahl, and Stephen F. Traynelis. Functional analysis of a de novo grin2a missense mutation associated with early-onset epileptic encephalopathy. Nature Communications, February 2014. URL: http://dx.doi.org/10.1038/ncomms4251, doi:10.1038/ncomms4251. This article has 123 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms4251)